Urba, Susan <br/><br/>
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study.  [electronic resource] 

 -  Cancer  Oct 2012 
 - 4694-705 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.27449  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Glutamates--administration & dosage<br/>Guanine--administration & dosage<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Pemetrexed<br/>Treatment Outcome